Accessibility Menu
Sandoz Group Ag logo

Sandoz Group Ag(OTC) SDZNY

Market Cap$39.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2023)+259%
5 YearN/A
1 Year+53%
1 Month+17%
$92.08
+0.60%
+0.55Today
Sandoz Group Ag last closing stock price
MetricPriceDate
Last closeUSD 92.082026-08-21
Sandoz Group Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.53%USD 89.812026-08-14
1 month+17.28%USD 78.512026-07-22
3 month+12.24%USD 82.042026-05-22
Year to date+28.06%USD 71.902025-12-31
1 year+53.46%USD 60.002025-08-21
Since inception+258.83%USD 25.662023-10-04

Sandoz Group Ag Financials at a Glance

Market Cap

$39.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$22.20B

Net Income (TTM)

$872.41M

EPS (TTM)

$1.48

P/E Ratio

61.77

Dividend

$1.02

Beta (Volatility)

0.00 (Low)

Price

$92.08

Volume

14,786

Open

$92.05

Previous Close

$92.08

Daily Range

$91.30 - $92.59

52-Week Range

$55.42 - $94.15

Estimated Earnings Date

Jul 2, 2024

SDZNY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sandoz Group Ag

Sandoz Group AG is a leading global provider of generic pharmaceuticals and biosimilars, dedicated to improving patient access to high-quality medicines. Founded in 1886 and headquartered in Basel, Switzerland, the company operates across various therapeutic areas, including oncology, infectious diseases, and diabetes.

Products and Services
  • Generic medications across multiple therapeutic areas
  • Biosimilars that offer alternatives to branded biologics
  • Active pharmaceutical ingredients and finished dosage forms
Growth Outlook
  • Projected growth in the global generic drug market, expected to reach $500 billion by 2025
  • Strong pipeline of new biosimilars anticipated to drive revenue growth
  • Expansion into emerging markets to enhance market share and revenue
Financial Highlights
  • Q2 2026 revenue of $5.77 billion, reflecting a stable performance
  • Trailing twelve months (TTM) net profit margin of 5.6%, indicating profitability
  • Dividend yield of 1.09%, providing a return to shareholders
Sandoz Group AG has established itself as a key player in the pharmaceutical industry, focusing on affordability and accessibility of medications. The company's diverse product portfolio and commitment to innovation position it well for future growth. Recent financial performance demonstrates resilience, with a solid revenue base and a focus on expanding its presence in high-growth markets. The ongoing development of biosimilars and generics aligns with global healthcare trends, making Sandoz a noteworthy consideration for potential investors.
AI Generated • Aug 20, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

23,000

CEO

Richard Saynor

Website

www.sandoz.com

Headquarters

Basel, ZG 4051, CH

SDZNY Financials

Key Financial Metrics (TTM)

Gross Margin

47.54%

Operating Margin

15.79%

Net Income Margin

5.62%

Return on Equity

7.04%

Return on Capital

11.38%

Return on Assets

2.84%

Earnings Yield

1.62%

Dividend Yield

1.11%

Payout Ratio

67.13%

Stock Overview

Market Cap

$39.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

432.70M

Volume

14.79K

Avg. Volume

22.81K

Financials (TTM)

Gross Profit

$10.47B

Operating Income

$2.41B

EBITDA

$3.50B

Operating Cash Flow

$2.67B

Capital Expenditure

-$935.95M

Free Cash Flow

$1.73B

Cash & ST Invst.

$1.25B

Total Debt

$6.20B

Sandoz Group Ag Performance Analysis

Sandoz Group Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 9,294,081,362-3.3%
20232023-12-31USD 9,984,600,7997.4%
20242024-12-31USD 10,351,142,0373.7%
20252025-12-31USD 11,142,770,1527.6%
Sandoz Group Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-314.8%
Q22025-06-30-1.1%
Q42025-12-3111.3%
Q22026-06-30-1.3%
Sandoz Group Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 1.97-6.4%
20232023-12-31USD 0.18-90.9%
20242024-12-31USD 0.00N/A
20252025-12-31USD 2.10N/A
Sandoz Group Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-200.0%
Q22025-06-30348.6%
Q42025-12-3142.5%
Q22026-06-30-79.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$5.77B

+13.8%

Gross Profit

$2.69B

+12.8%

Gross Margin

46.61%

N/A

Market Cap

$39.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.73M

N/A

Employees

23,000

N/A

Net Income

$109.24M

-27.4%

EBITDA

$1.12B

+106.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$1.25B

+78.3%

Total Debt

$6.20B

+39.6%

Accounts Receivable

$2.94B

+12.1%

Inventory

$2.79B

-3.4%

Long Term Debt

$4.75B

+16.0%

Short Term Debt

$1.45B

+314.6%

Return on Assets

2.84%

N/A

Return on Invested Capital

12.57%

N/A

Free Cash Flow

$606.31M

+844.9%

Operating Cash Flow

$872.89M

+280.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OTSKYOtsuka Holdings Co., Ltd.
$38.53-2.18%
OTSKFOtsuka Holdings Co., Ltd.
$77.53+0.00%
HLNCFHaleon plc
$4.81-0.31%
TEVJFTeva Pharmaceutical Industries Limited
$37.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About SDZNY

What is the current price of Sandoz Group Ag?

Sandoz Group Ag is trading at $92.08 per share.

What is the 52-week range for Sandoz Group Ag?

Over the past 52 weeks, Sandoz Group Ag has traded between $55.42 and $94.15.

How much debt does Sandoz Group Ag have?

As of the most recent reporting period, Sandoz Group Ag reported total debt of $5.68B.

How much cash does Sandoz Group Ag have on hand?

Sandoz Group Ag reported $1.74B in cash and cash equivalents in its most recent financial results.

What is Sandoz Group Ag’s dividend yield?

Sandoz Group Ag currently has a dividend yield of 1.11%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services